Use of Second-Generation Antidiabetic Medication Among a Nat

Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer antidiabetic agents.

Related Keywords

South Korea , Silver Spring , Washington , United States , Jordan , Americans , American , Han , Exenatide Byetta , Sitagliptin Januvia , Falal Invokana , Empagliflozin Jardiance , Jingjing Qian , Canovatchelw Canagliflozin , Coricaf Incalzi , Us Department Of Agriculture , Society For Health Economics , Outcomes Research , Department Of Health Outcomes Research , Walravenc Association , Nutrition Examination Survey , Vital Health Stat , American Diabetes Association , National Diabetes Statistics , Vasc Health Risk Manag , Study Group , European Association For The Study Of Diabetes , Department Of Mathematics , National Health , Novo Nordisk , Nutrition Examination , Auburn University College Of Sciences , World Health Organization , Auburn University Institutional Review Board , Auburn University Harrison College Of Pharmacy , Examination Center , Medicare Part , Data Sources , Auburn University Institutional Review , Multum Medisource Lexicon , Appendix Table , Demographic Variables , Sample Weights , Hispanic Black , Hispanic White , Dietary Guidelines , Ecigarette Use , Physical Activity , Body Measures , Physical Functioning , Dietary Interview , Total Nutrient Intakes , Medical Conditions , Chronic Kidney Disease Epidemiology Collaboration , Kidney Disease , Improving Global Outcomes , Prescription Medications , Mobile Examination Center , Factors Associated With , Second Generation Antidiabetic Medications , Health Outcomes Research , Auburn University Harrison College , Auburn University College , Professional Society , Health Economics , Walker Building , Diabetes Statistics Report , Updated April , European Association , Medical Care , Accessed December , Health Stat , Nutrition Examination Surveys , Clin Risk , Diabetes Res Clin , Health Risk , Diabetes , Medication , Comorbidity ,